SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Nasdaq
Börse Nasdaq
ISIN IE00BYZ5XL97
USD
  • Strongbridge Biopharma PLC
    Börse Nasdaq
    ISIN IE00BYZ5XL97 WKN: A14Z67
    Symbol SBBP
    USD
  • ISIN IE00BYZ5XL97 WKN: A14Z67
    Symbol SBBP
    USD
ISIN IE00BYZ5XL97
WKN A14Z67
Symbol SBBP
Währung USD
Börse Nasdaq Zeitzone: America/New_York
Marktkapitalisierung 168.113.992 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

178.227.984 oder 158.000.000

Mitarbeiter 72
KGV 4.27
EBITDA -74.521.000
Buchwert 0.976

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 2,3 EUR -1,70% 

28 News & Informationen zur Strongbridge Biopharma PLC Aktie

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., Aug. 05, 2021 (GLOBE NEWSWIRE) — FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER…

  • Earnings Scheduled For August 5, 2021
    benzinga.com

    Earnings Scheduled For August 5, 2021

    Companies Reporting Before The Bell
    • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of …

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., Aug. 03, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…

  • Xeris Pharmaceuticals : Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
    marketscreener.com

    Xeris Pharmaceuticals : Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue

    Xeris Pharmaceuticals, Inc. today announced in accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013 that, as of the close of business on July 28, 2021, Xeris'… | July 29, 2021

  • Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
    finanzen.net

    Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue

    Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue | Nachricht | finanzen.net

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., July 27, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES…

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., July 26, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH…

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., July 23, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., July 22, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., July 21, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,…

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., July 20, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…

  • AxoGen : Global leader brings 30+ years of biopharma experience to Axogen, Inc. Board of Directors (Form 8-K)
    marketscreener.com

    AxoGen : Global leader brings 30+ years of biopharma experience to Axogen, Inc. Board of Directors (Form 8-K)

    Global leader brings 30+ years of biopharma experience to Axogen, Inc. Board of Directors

    ALACHUA and TAMPA, FL – July 19, 2021 – Axogen, Inc. , a global leader in developing… | July 19, 2021

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., July 08, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations
    marketscreener.com

    SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations

    NEW YORK, July 7, 2021 /PRNewswire/ —

    If you own shares in any of the companies… | July 7, 2021

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations
    thestreet.com

    SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations

    NEW YORK, July 7, 2021 /PRNewswire/ —

    If you own shares in any of the companies listed above and would like to discuss our investigations or have

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., July 06, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…

  • INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, RIVE, ESXB, ICON, SBBP; Shareholders are Encouraged to Contact the Firm
    marketscreener.com

    INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, RIVE, ESXB, ICON, SBBP; Shareholders are Encouraged to Contact the Firm

    NEW YORK, July 3, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

    … | July 4, 2021

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., July 02, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,…

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds KNL, DTRC, SBBP, and CNST Shareholders About Its Ongoing Investigations
    markets.businessinsider.com

    SHAREHOLDER ALERT: WeissLaw LLP Reminds KNL, DTRC, SBBP, and CNST Shareholders About Its Ongoing Investigations

    NEW YORK, June 29, 2021 /PRNewswire/ –If you own shares in any of the companies listed above and would like to discuss our investigations or have…

  • Marker Therapeutics, Inc. (MRKR): Are Hedge Funds Right About This Stock?
    insidermonkey.com

    Marker Therapeutics, Inc. (MRKR): Are Hedge Funds Right About This Stock?

    The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers…

  • Form 8.3 - The Vanguard Group, Inc. : Strongbridge Biopharma plc
    marketscreener.com

    Form 8.3 – The Vanguard Group, Inc. : Strongbridge Biopharma plc

    The Vanguard Group, Inc.
    Form 8.3 – The Vanguard Group, Inc.: Strongbridge Biopharma plc
    25-Jun-2021 / 14:19 GMT/BST
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
    The… | June 25, 2021

  • Man Group PLC : Form 8.3 - Strongbridge Biopharma plc
    globenewswire.com

    Man Group PLC : Form 8.3 – Strongbridge Biopharma plc

    Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH…

  • Best Penny Stocks to Buy Right Now? 15 To Watch In July
    pennystocks.com

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., June 24, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,…

  • INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm
    marketscreener.com

    INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm

    NEW YORK, June 24, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

    … | June 24, 2021

  • INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm
    prnewswire.com

    INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm

    /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Nicolet Bankshares, Inc. (NASDAQ:…

  • DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
    globenewswire.com

    DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

    BEND, Ore., June 23, 2021 (GLOBE NEWSWIRE) — Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER…

  • 12 Health Care Stocks Moving In Monday's After-Market Session
    benzinga.com

    12 Health Care Stocks Moving In Monday’s After-Market Session

    Gainers
    Jaguar Health (NASDAQ:JAGX) shares moved upwards by 18.53% to $2.11 during Monday’s after-market session. This security traded at a volume of …

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Dir gefallen die Informationen zu Strongbridge Biopharma PLC?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Strongbridge Biopharma PLC?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Strongbridge Biopharma PLC?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Strongbridge Biopharma PLC?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba